Paraneoplastic syndrome: Difference between revisions
No edit summary |
|||
Line 11: | Line 11: | ||
==Classification== | ==Classification== | ||
* Paraneoplastic syndromes may be [[Classification|classified]] into 4 main categories: | * Paraneoplastic syndromes may be [[Classification|classified]] into 4 main categories: | ||
**[[Endocrine|Endocrine metabolic]] [[Syndrome|syndromes]]: | **[[Endocrine|Endocrine metabolic]] [[Syndrome|syndromes]]: | ||
***[[Hypercalcemia]] in [[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]]) | ***[[Hypercalcemia]] in [[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]]) | ||
****Seen in [[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]] | ****Seen in [[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]] | ||
***[[Syndrome of inappropriate antidiuretic hormone|SIADH]] | ***[[Syndrome of inappropriate antidiuretic hormone|SIADH]] | ||
****Associated [[Cancer|cancers]]: [[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]] | ****Associated [[Cancer|cancers]]: [[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]] | ||
***[[Ectopic]] [[ACTH]] [[secretion]] associated with [[Small cell lung cancer|small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]] and other [[Cancer|cancers]] | ***[[Ectopic]] [[ACTH]] [[secretion]] associated with [[Small cell lung cancer|small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]] and other [[Cancer|cancers]] | ||
***[[Tumor induced osteomalacia]] | ***[[Tumor induced osteomalacia]] | ||
***[[Hypoglycemia]] | ***[[Hypoglycemia]] | ||
****Associated [[Cancer|cancers]]: [[Gastrointestinal tract|GI]], [[mesothelioma]], [[lung]], and [[sarcomas]] | ****Associated [[Cancer|cancers]]: [[Gastrointestinal tract|GI]], [[mesothelioma]], [[lung]], and [[sarcomas]] | ||
**[[Mucocutaneous|Musculocutaneous]] paraneoplastic syndromes | **[[Mucocutaneous|Musculocutaneous]] paraneoplastic syndromes | ||
***[[Dermatomyositis]] (25-50% of adult patients have an underlying [[malignancy]]) | ***[[Dermatomyositis]] (25-50% of adult patients have an underlying [[malignancy]]) | ||
***[[Leser-Trelat sign|Leser-Trélat sign]], a sudden onset of many [[Pigmented lesions|pigmented]] [[skin]] lesions | ***[[Leser-Trelat sign|Leser-Trélat sign]], a sudden onset of many [[Pigmented lesions|pigmented]] [[skin]] lesions | ||
Line 27: | Line 27: | ||
***[[Sweet's syndrome]] | ***[[Sweet's syndrome]] | ||
***[[Pyoderma gangrenosum]] | ***[[Pyoderma gangrenosum]] | ||
**[[Neurological]] paraneoplastic syndromes: | **[[Neurological]] paraneoplastic syndromes: | ||
***[[Paraneoplastic cerebellar degeneration]] associated with [[lung]], [[ovarian]], [[breast]], [[lymphatic]], and other cancers | ***[[Paraneoplastic cerebellar degeneration]] associated with [[lung]], [[ovarian]], [[breast]], [[lymphatic]], and other cancers | ||
***[[Encephalomyelitis]] ([[inflammation]] of the [[brain]] and [[spinal cord]]) | ***[[Encephalomyelitis]] ([[inflammation]] of the [[brain]] and [[spinal cord]]) | ||
Line 33: | Line 33: | ||
***[[Encephalitis|Brainstem encephalitis]] | ***[[Encephalitis|Brainstem encephalitis]] | ||
***[[Opsoclonus]] (involving eye movement) | ***[[Opsoclonus]] (involving eye movement) | ||
***[[Encephalitis]] triggered by a [[teratoma]] | ***[[Encephalitis]] triggered by a [[teratoma]] | ||
***[[Polymyositis]] | ***[[Polymyositis]] | ||
***[[Lambert-Eaton myasthenic syndrome]] ([[LEMS]]) in [[Small cell lung cancer|small-cell lung cancer]] | ***[[Lambert-Eaton myasthenic syndrome]] ([[LEMS]]) in [[Small cell lung cancer|small-cell lung cancer]] | ||
Line 39: | Line 39: | ||
***Subacute (peripheral) [[sensory neuropathy]] | ***Subacute (peripheral) [[sensory neuropathy]] | ||
***[[Autonomic neuropathy]] | ***[[Autonomic neuropathy]] | ||
**[[Hematological]] paraneoplastic syndromes | **[[Hematological]] paraneoplastic syndromes | ||
***[[Granulocytosis]] (increased [[granulocyte]]s) due to the production of [[Granulocyte colony-stimulating factor|G-CSF]] | ***[[Granulocytosis]] (increased [[granulocyte]]s) due to the production of [[Granulocyte colony-stimulating factor|G-CSF]] | ||
*** [[Eosinophilia]] | *** [[Eosinophilia]] | ||
Line 48: | Line 48: | ||
==Causes== | ==Causes== | ||
===Common Causes=== | ===Common Causes=== | ||
* The major [[causes]] of paraneoplastic syndrome include: | * The major [[causes]] of paraneoplastic syndrome include: | ||
**[[Small cell lung cancer]] | **[[Small cell lung cancer]] | ||
** [[Non-small cell lung cancer]] | **[[Non-small cell lung cancer]] | ||
** [[ | **[[Multiple myeloma]] | ||
** [[Breast cancer]] | **[[Breast cancer]] | ||
** [[Medullary thyroid cancer]] | **[[Medullary thyroid cancer]] | ||
** [[Bronchial]] [[carcinoid]] | **[[Bronchial]] [[carcinoid]] | ||
** [[Pancoast tumor|Pancoast's tumour]] | **[[Pancoast tumor|Pancoast's tumour]] | ||
** [[Pancreatic cancer]] | **[[Pancreatic cancer]] | ||
** [[Hepatocellular carcinoma]] | **[[Hepatocellular carcinoma]] | ||
** [[Gastric tumors]] | **[[Gastric tumors]] | ||
** [[Gastrointestinal]] [[neuroendocrine tumors]] (NETS) | **[[Gastrointestinal]] [[neuroendocrine tumors]] (NETS) | ||
** [[Leukemias]] | **[[Leukemias]] | ||
** [[Lymphomas]] | **[[Lymphomas]] | ||
** [[Skin cancers]] | **[[Skin cancers]] | ||
** [[Renal carcinoma]] | **[[Renal carcinoma]] | ||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
*Paraneoplastic syndromes [[causes]] may be regrouped by organ system. | *Paraneoplastic syndromes [[causes]] may be regrouped by organ system. | ||
{| style="width:82%; height:100px" border="1" | {| style="width:82%; height:100px" border="1" | ||
|- | |- | ||
Line 248: | Line 248: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Cough]] | * [[Cough]] | ||
Line 278: | Line 278: | ||
* [[Hilar|Hilar mass]] | * [[Hilar|Hilar mass]] | ||
| style="background: #F5F5F5; padding: 5px;" | _ | | style="background: #F5F5F5; padding: 5px;" | _ | ||
| style="background: #F5F5F5; padding: 5px;" |Small, round and oval cells | | style="background: #F5F5F5; padding: 5px;" | | ||
[[Necrotic|Necrosis]] | * Small, round and oval cells | ||
* [[Necrotic|Necrosis]] | |||
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]] | | style="background: #F5F5F5; padding: 5px;" |[[Biopsy]] | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Asymptomatic]] at first | * [[Asymptomatic]] at first | ||
Line 321: | Line 323: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Asymptomatic]] at first | * [[Asymptomatic]] at first | ||
Line 346: | Line 348: | ||
* ↑ [[Alpha fetoprotein]] | * ↑ [[Alpha fetoprotein]] | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
*[[Ultrasonography|U/S]] : Small hypoechoic lesion | |||
* Irregular border with [[fibrosis]], and [[calcification]] | |||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Tumor cell|Polygonal tumor cells]] | * [[Tumor cell|Polygonal tumor cells]] | ||
Line 375: | Line 377: | ||
!Additional findings | !Additional findings | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Lump]] in the [[breast]] | * [[Lump]] in the [[breast]] | ||
Line 408: | Line 410: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Hematuria]] | *[[Hematuria|Dark urine]] | ||
* [[Flank pain]] | * [[Flank pain]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 436: | Line 438: | ||
* ↑ [[LDH]] | * ↑ [[LDH]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* ↑ | * ↑ Creatinine | ||
* | * Cancer cells in [[Urine|urine cytology]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Abdominal]] CT scan: | * [[Abdominal]] CT scan: | ||
** Thickened irregular walls | ** Thickened irregular walls | ||
** | ** Neoplastic mass | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
Line 450: | Line 452: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Epigastric]] [[pain]] | * [[Epigastric]] [[pain]] | ||
Line 494: | Line 496: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* History of [[gastric ulcer]] | * History of [[gastric ulcer]] | ||
Line 523: | Line 525: | ||
** Loss of [[Rugal folds|rugal fold]] | ** Loss of [[Rugal folds|rugal fold]] | ||
** [[Mucosal]] irregularity Ulcerative lesion | ** [[Mucosal]] irregularity Ulcerative lesion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Endoscopy]]: [[Ulcer]] | * [[Endoscopy]]: [[Ulcer]] | ||
| style="background: #F5F5F5; padding: 5px;" |_ | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Irregular [[tubular]] structure | * Irregular [[tubular]] structure | ||
Line 540: | Line 542: | ||
* [[Acanthosis nigricans]] | * [[Acanthosis nigricans]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Weight loss]] | * [[Weight loss]] | ||
Line 569: | Line 571: | ||
| style="background: #F5F5F5; padding: 5px;" |_ | | style="background: #F5F5F5; padding: 5px;" |_ | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Asymptomatic]] at first | * [[Asymptomatic]] at first | ||
Line 600: | Line 602: | ||
* [[Psammoma body|Psammoma bodies]] | * [[Psammoma body|Psammoma bodies]] | ||
* [[Necrosis]] | * [[Necrosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Biopsy]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Trousseau's syndrome|Trousseau]] [[syndrome]] | * [[Trousseau's syndrome|Trousseau]] [[syndrome]] | ||
Line 610: | Line 613: | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
<references /> |
Revision as of 16:08, 11 October 2019
PCFor patient information, click here
Paraneoplastic syndrome Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]
Synonyms and keywords: Paraneoplastic syndrome
Overview
Paraneoplastic syndromes are a rare type of disease that is caused by abnormal immune systems resulting from cancerous cells. Paraneoplastic syndromes are disorders due to the release of hormones, or peptides that cause immune cross-reactivity between cancerous cells and normal tissues. Sometimes the symptoms of paraneoplastic syndromes show even before the diagnosis of a malignancy. There is no screening for paraneoplastic syndromes. The stage and type of diagnosis of cancer determine the prognosis of a paraneoplastic syndrome. The causes are mostly related to the organ affected. The paraneoplastic syndromes are divided into four main categories such as musculocutaneous, neurological, hematological and endocrines. They are no cures for the paraneoplastic syndrome, but cancer treatment and some medications to reduce autoimmune responses are helpful.
Classification
- Paraneoplastic syndromes may be classified into 4 main categories:
- Endocrine metabolic syndromes:
- Hypercalcemia in breast cancer and lung cancer (typically squamous cell) due to the production of PTHrP (Parathyroid hormone-related protein)
- Seen in multiple myeloma, renal cell carcinoma, ovarian cancer, endometrial cancer, and lymphoma
- SIADH
- Associated cancers: small cell lung cancer, mesothelioma, breast, prostate, adrenal, urethral, thymoma, lymphoma, GI, CNS, and Ewing sarcoma
- Ectopic ACTH secretion associated with small-cell lung cancer, carcinoid tumor, thymoma and other cancers
- Tumor induced osteomalacia
- Hypoglycemia
- Associated cancers: GI, mesothelioma, lung, and sarcomas
- Hypercalcemia in breast cancer and lung cancer (typically squamous cell) due to the production of PTHrP (Parathyroid hormone-related protein)
- Musculocutaneous paraneoplastic syndromes
- Dermatomyositis (25-50% of adult patients have an underlying malignancy)
- Leser-Trélat sign, a sudden onset of many pigmented skin lesions
- Acanthosis nigricans
- Necrolytic migratory erythema
- Sweet's syndrome
- Pyoderma gangrenosum
- Neurological paraneoplastic syndromes:
- Paraneoplastic cerebellar degeneration associated with lung, ovarian, breast, lymphatic, and other cancers
- Encephalomyelitis (inflammation of the brain and spinal cord)
- Limbic encephalitis
- Brainstem encephalitis
- Opsoclonus (involving eye movement)
- Encephalitis triggered by a teratoma
- Polymyositis
- Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer
- Myasthenia gravis
- Subacute (peripheral) sensory neuropathy
- Autonomic neuropathy
- Hematological paraneoplastic syndromes
- Granulocytosis (increased granulocytes) due to the production of G-CSF
- Eosinophilia
- Pure red cell aplasia
- Thrombocytosis
- Others:
- Endocrine metabolic syndromes:
Causes
Common Causes
- The major causes of paraneoplastic syndrome include:
Causes by Organ System
- Paraneoplastic syndromes causes may be regrouped by organ system.
Dermatologic | |
Ear Nose Throat | |
Endocrine | |
Gastroenterologic |
|
Hematologic | |
Musculoskeletal/Orthopedic | |
Neurologic | |
Obstetric/Gynecologic | |
Oncologic | |
Pulmonary | |
Renal/Electrolyte | |
Rheumatology/Immunology/Allergy |
|
Urologic | |
Miscellaneous |
Differential diagnosis
Paraneoplastic syndromes must be differentiated from others types of cancer depending on the location and type of organs.
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Small cell lung cancer |
|
_ |
|
_ |
|
Biopsy | _ | ||||||||
Squamous lung cancer |
|
|
|
|
_ | _ |
|
_ |
|
_ | |||||
Hepatocellular carcinoma |
|
_ |
|
_ | _ |
|
_ | ||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Breast cancer |
|
|
|
|
_ | _ | _ | _ | _ |
|
_ | ||||
Renal cancer |
|
|
|
_ | _ |
|
_ | ||||||||
Pancreatic cancer |
|
|
_ |
|
_ | ||||||||||
Gastric cancer |
|
_ |
|
_ |
|
_ |
|
| |||||||
Lymphoma | _ |
|
|
_ | _ | _ |
|
_ | |||||||
Ovarian cancer |
|
|
|
|
_ | _ |
|